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Mycobacterium tuberculosis (Mtb) is an intracellular patho-
gen that infects alveolar macrophages following aerosol trans-
mission. Lung macrophages provide a critical intracellular 
niche that is required for Mtb to establish infection in the 
human host. This parasitic relationship is made possible by the 
capacity of Mtb to block phagosome maturation following entry 
into the host macrophage, creating an environment that supports 
bacillary replication. Apoptosis is increasingly understood to 
play a role in host defense against intracellular pathogens 
including viruses, fungi, protozoa and bacteria. In the last 15 
years an understanding of the role that macrophage apoptosis 
plays in TB has begun to emerge. Here we review the history 
and current state of the art of this topic and we offer a model 
of the macrophage-pathogen interaction that takes into the 
account the complexities of programmed cell death and the 
relationship between various death signaling pathways and 
host defense in TB.
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INTRACELLULAR PARASITISM BY TUBERCLE 
BACILLI
Mycobacterium tuberculosis (Mtb), the causative 
agent of tuberculosis (TB), is a facultative intracel-
lular parasite of macrophages. The bacillus is 
non-motile and lacks the secreted toxins used by 
extracellular bacterial pathogens to fashion an 
environment suitable for growth in the infected 
host. In order for Mtb to establish infection it must 
first gain entry into resident alveolar macrophages 
following inhalation of infectious aerosols. Macro-
phages patrolling the distal airways avidly engulf 
inhaled bacteria using a variety of phagocytic 
receptors. A number of different phagocytic recep-
tors have been implicated in Mtb entry to macro-
phages, with complement receptor and mannose 
receptor likely the predominant pathways.
1,2 After 
phagocytosis, non-pathogenic bacteria are de-
graded by the acidification of the phagosomal 
compartment and its subsequent fusion with 
lysosomes that contain hydrolases active at low 
pH. Keys to the virulence of Mtb are its capacity 
to prevent the incorporation of the ATP/proton 
pump into the phagosome membrane and to 
restrict the fusion of this vacuole with lysosomes.
3 
Protected in a compartment with features of an 
early endosome, tubercle bacilli are capable of 
replication unless their growth is restricted by 
interferon (IFN)-γ mediated activation of the host 
macrophage.
4
An initial phase of intracellular growth in lung 
macrophages is required for Mtb to establish pro-
ductive infection in the host. This point was demon-
strated in experiments where resident alveolar 
macrophages were depleted in mice using liposome- 
encapsulated dichloromethylene diphosphonate 
prior to aerosol infection with Mtb.
5 Mice depleted 
of alveolar macrophages were relatively protected 
from Mtb infection, whereas the same macrophage 
depletion method dramatically increased the sus-
ceptibility of mice to infection with Streptococcus 
pneumoniae.
6 These findings indicate that alveolar 
macrophages play a protective role in host defense 
against a typical extracellular bacterial pathogen 
but facilitate infection with Mtb at least until they 
can be activated by IFN-γ provided from T cells.
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In later stages of active pulmonary TB the bacilli 
can adopt an extracellular lifestyle in foci of ne-
crosis. Lung cavities that connect to airways pro-
vide an oxygen-rich environment permitting extra-
cellular Mtb to reach high densities and an open 
pathway for transmission.
7 Lacking an environm-
ental reservoir Mtb depends on aerosol transmis-
sion between human hosts for its persistence, 
highlighting the importance of the transition from 
intracellular to extracellular infection. From these 
considerations it is clear that the interaction 
between  Mtb bacilli and host macrophages is a 
central element of TB pathogenesis. 
APOPTOSIS AS A DEFENSE AGAINST 
INTRACELLULAR PARASITISM
When confronted with a pathogen that uses 
host cellular resources for survival and replication 
one strategy for defense is to activate the program-
med death (apoptosis) of the host cell. Apoptosis 
in response to intracellular parasitism by viruses 
is a well established paradigm in biology.
8 Many 
successful viral pathogens encode genes whose 
products suppress apoptosis of the host cell, 
thereby sustaining the niche for viral replication.
9-13 
The extension of this paradigm to intracellular 
bacterial pathogens is more recent but a large 
number of cases have now been identified, in-
cluding macrophage infection by Mtb as discussed 
below. 
Apoptosis is a highly regulated process of cel-
lular deconstruction that confines the cytoplasmic 
contents of dying cells within membrane bound 
vesicles (apoptotic bodies) that express "eat me" 
signals on their surface. Apoptotic bodies are 
recognized and avidly engulfed by professional 
phagocytes via a number of specific cell surface 
receptors; a process called efferocytosis. Binding 
of apoptotic bodies typically stimulates the expres-
sion of anti-inflammatory cytokines including 
transforming growth factor-β  and interleukin-10 
(IL-10).
14,15 By suppressing inflammation these 
cytokines are thought to help limit the tissue 
damage that might occur if intracellular contents, 
particularly degradative enzymes, were released 
to the extracellular space. Apoptosis of infected 
cells might benefit the host in several ways. It 
eliminates a protected intracellular environment 
favorable for replication, forcing the infecting 
pathogen to reestablish residence in a naïve host 
cell. In addition to orchestrating the quiet elimina-
tion of parasitized cells, packaging of pathogen- 
specific molecules in apoptotic bodies serves as an 
efficient pathway for the delivery of antigens fol-
lowing efferocytosis by immature dendritic cells.
16 
It is also recognized that in some circumstances 
infection-induced apoptosis might serve the in-
terests of the pathogen rather than the host. 
Potential mechanisms for apoptosis associated 
with disease promotion include the elimination of 
vital host defense cells, penetration of epithelial 
barriers and dissemination of infection by the 
delivery of pathogens to naïve host phagocytes 
engulfing apoptotic corpses.
13
CELL DEATH PATHWAYS
Before discussing apoptosis of Mtb-infected 
macrophages it may be helpful to briefly review 
the major pathways and modes of programmed 
cell death. Caspases belong to a family of cysteine 
proteases whose functions are central to the initia-
tion and execution of many forms of apoptosis. 
Members of the caspase family share structural 
characteristics (they are expressed as proenzymes) 
and substrate specificities, cleaving targets with 
similar tetrapeptide motifs having aspartic acid in 
the P1 position.
17 Procaspases are activated by 
proteolytic processing at an internal aspartic acid 
residue, which may result from autoproteolysis, 
cleavage by different caspases or cleavage by non- 
caspase proteases. Caspase activation and sub-
sequent apoptosis can be triggered by at least 
three distinct pathways. The extrinsic apoptosis 
pathway is induced after ligation and oligomeri-
zation of tumor necrosis receptor (TNFR) family 
cell surface receptors including TNFR1 and Fas 
(among others) by their cognate ligands tumor 
necrosis factor (TNF)-α and Fas ligand (FasL).
18 A 
death-inducing signal complex (DISC) is then 
formed by recruitment of Fas-associated death 
domain and the initiator procaspases-8 or -10 that 
are autoactivated at the DISC. These initiator 
caspases trigger a cascade of downstream caspases 
through proteolytic processing of their precursor Macrophage Apoptosis in Tuberculosis 3
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zymogens, terminating with the activation of 
effector caspases including caspase-3, -6 and -7 
whose functions, along with a number of non- 
caspase enzymes, result in nuclear condensation, 
DNA cleavage and the formation of apoptotic 
vesicles.
19 
The intrinsic apoptosis pathway is induced by 
intracellular stresses such as DNA damage, nutrient 
deprivation and oxidative stress. These triggers 
promote mitochondrial outer membrane permea-
bility, permitting cytosolic translocation of cyto-
chrome c. In the cytosol, cytochrome c associates 
with procaspase-9 and apoptosis protease acti-
vating factor-1 to form a signaling complex called 
the apoptosome.
20 Activated caspase-9 in turn 
promotes to the downstream activation of effector 
caspases and the induction of apoptosis. Mito-
chondrial permeability is controlled by the inte-
gration of pro-apoptotic and anti-apoptotic actions 
of the BCL-2 family of proteins.
21 Pro-apoptotic 
BAX and BAK form pores in the mitochondrial 
outer membrane, permitting cytochrome c release. 
This is opposed by anti-apoptotic family members 
including BCL-2, BCLX-L and Mcl-1. Cell fate is 
thus determined by the integration of signals 
mediating the activities of both pro- and anti- 
apoptotic BCL-2 family proteins. An upstream pro- 
apoptotic BCL-2 protein called BID is activated by 
enzymatic cleavage to truncated form (tBID), which 
orchestrates the activities of BAX and BAK to 
promote cytochrome c release. Cleavage of BID 
can be mediated by a number of proteases and is 
a characteristic of most intrinsic apoptosis path-
ways. Capase-8 can also cleave and activate BID, 
permitting cross-talk between the extrinsic and 
intrinsic apoptosis pathways. 
A third pathway of caspase activation is medi-
ated by granzyme B released from cytotoxic T 
lymphocytes (CTL) and NK cells. Co-release of 
perforin enables granzyme B to enter target cells 
where the substrates for its serine protease 
activity include caspase-3 and other caspases. The 
effect of granzyme B and certain other CTL granule 
enzymes is to produce the apoptotic death of 
target cells. 
In addition to these classical cell death pathways 
a growing number of other pathways have been 
identified, some of which produce an apoptotic or 
necrotic modes of programmed cell death that 
may in different cases be dependent on or inde-
pendent of caspase activity.
22,23 Most of these 
alternative pathways involve mitochondrial injury 
mediated by BAX or BAK. Major examples of 
such pathways include lysosomal apoptosis and 
pyroptosis. Lysosomal apoptosis occurs following 
lysosomal membrane permeabilization (LMP), 
which can be induced by oxidative stress, bile 
salts or chemotherapeutic drugs among other 
stimuli.
24,25 Lysosomes contain numerous proteases 
of diverse classes collectively called cathepsins. 
Many cathepsins are stored as proenzymes that 
become activated at low pH in phagolysosomes. 
Lysosomal enzymes accidentally released into the 
cytosol can trigger programmed cell death by 
directly damaging mitochondrial membranes or 
indirectly by cleaving BID and initiating apoptosis 
through BAX-mediated cytochrome c release.
26 
Pyroptosis involves caspase-1-mediated activation 
of death-inducing enzymes including nucleases, 
but does not involve effector caspases.
27 Examples 
of macrophage pyroptosis has been reported 
following infection with Francisella tularensis, Listeria 
monocytogenes and Shigella flexneri.
28-30 Finally, ex-
trinsic factors may promote apoptosis by directly 
causing injury to the outer mitochondrial mem-
brane independent of BAX or BAK. One example 
of this is the VacA toxin produced by Helicobacter 
pylori.
31 VacA contains a mitochondrial localiza-
tion motif and organizes the formation of pore in 
the outer mitochondrial membrane, triggering 
apoptosis.
Mtb ACTIVATES THE EXTRINSIC APOP-
TOSIS PATHWAY IN MACROPHAGES
In 1997 Keane et al.
32 first reported that infec-
tion of human alveolar macrophages by Mtb at a 
multiplicity of infection (MOI) of ~5 bacilli per cell 
was sufficient to induce classical, extrinsic apop-
t o s i s .  T h i s  c e l l  d e a t h  w a s  s h o w n  t o  b e  m e d i a t e d  
by TNF-α in an autocrine/paracrine manner. It is 
well recognized that binding of Mtb by macrophages 
is a potent stimulus for TNF-α production. Naïve 
macrophages were shown to be insensitive to 
TNF-α-mediated apoptosis, but these cells became 
primed by the presence of live, intracellular myco-
bacteria to activate the TNFR1 death pathway. Jinhee Lee, et al. 4
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Blocking phagocytosis with cytochalasin D or 
heat-inactivating Mtb prevented macrophage cyto-
toxicity. Another key finding in this study was 
that the attenuated Mtb strain H37Ra was a much 
more potent inducer of apoptosis than the virulent 
strain H37Rv despite comparable production of 
TNF-α. Subsequent studies confirmed the inverse 
correlation of Mtb virulence and the induction of 
classical apoptosis at low MOI.
33 This relationship 
is consistent with the hypothesis that TNF-α- 
mediated apoptosis of Mtb-infected macrophages 
is a defensive response, a model that was further 
supported by the discovery that virulent Mtb 
strains actively suppress apoptosis by interfering 
with TNF-α signaling and by upregulating the ex-
pression of anti-apoptotic Mcl-1.
34-36 The competing 
signals promoting activation and suppression of 
apoptosis in Mtb-infected macrophages is reminis-
cent of the pro-death and countervailing pro-sur-
vival signals in host cells infected with viruses. 
 
CLASSICAL APOPTOSIS PROMOTES HOST 
DEFENSE IN TB
By denying infecting bacilli a protected intracel-
lular environment for bacillary replication, TNF-α- 
mediated macrophage apoptosis presumably 
represents an innate defense that slows the in-
crease of bacillary load following infection. How-
ever, this is not the only means by which apoptosis 
benefits the host in TB. Prior to the discovery of 
an intrinsic apoptosis response to Mtb infection, 
Molloy et al.
37 reported that inducing apoptosis of 
BCG-infected monocytes by exogenous drug treat-
ment was accompanied by a reduction in bacillary 
viability. In contrast, when infected cells were 
made to undergo necrosis there was no reduction 
in BCG viability. The concept that apoptosis exerts 
a direct antimicrobial effect on intracellular myco-
bacteria was later supported by the demonstration 
that the viability of several apoptosis-inducing, 
attenuated mycobacterial strains (Mtb H37Ra, 
BCG and M. kansasii) was reduced as their host 
macrophages died.
33 In contrast, several virulent 
Mtb strains that provoked little or no macrophage 
apoptosis all demonstrated intracellular growth in 
culture. This paradigm has held up in several sub-
sequent studies,
38-40 although the precise mechanism 
of the direct antimicrobial activity exerted in 
macrophages undergoing apoptosis has not been 
elucidated.
An indirect antimicrobial function of apoptosis 
was suggested by Fratazzi et al.
41 in experiments 
using an apoptosis-inducing strain of M. avium. 
Adding fresh, uninfected macrophages to cultures 
of infected macrophages that were undergoing 
apoptosis was associated with reduced mycobac-
terial viability but this was not seen if the initially 
infected macrophages were rendered necrotic. The 
authors showed that killing M. avium in this 
"add-back" culture system was contact-dependent, 
suggesting that it might involve engulfment by 
naïve macrophages of bacilli contained within 
apoptotic bodies. Similar results were reported by 
Lee et al.
42 using Mtb in a high-MOI challenge 
condition described below. In this system the in-
itially infected macrophages exhibit features of 
apoptosis 3 hours post-infection. Adding naïve 
macrophages to the infected cells at this early time 
point resulted in a reduction of Mtb viability. If 
naïve macrophages were added at a later time 
point (18 hours) when the initially infected macro-
phages had progressed to necrosis, there was no 
evident negative impact on bacillary viability and 
growth of Mtb was observed. One explanation for 
these findings is that efferocytosis of apoptotic 
bodies harboring Mtb overcomes the typical res-
triction to phagosomal acidification and lysosome 
fusion orchestrated by the bacilli and instead 
delivers the microbes to an inhospitable, acidified 
phagolysosome. 
While efferocytosis of Mtb-infected apoptotic 
corpses by macrophages might enhance host de-
fense by killing bacilli, efferocytosis by dendritic 
cells (DC) makes a unique contribution to TB de-
fense by promoting adaptive immunity. Schaible 
et al.
16 isolated apoptotic vesicles from BCG-infected 
macrophages and fed them to immature DC. 
Following uptake of these particles, the DC effici-
ently activated antigen-specific T cells including 
class I MHC restricted CD8+ T cells. This finding 
suggested that macrophage apoptosis could benefit 
the host by enhancing the priming of adaptive 
immunity which is critical to TB defense, and in 
particular by facilitating cross-priming of exogen-
ous  Mtb antigen to activate CTL. In vivo valida-
tion of this model was provided by the identifica-Macrophage Apoptosis in Tuberculosis 5
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tion of Mtb genes, including nuoG and secA2, 
required for the suppression of apoptosis by 
virulent  Mtb strains.
40,43 Mutation of the secA2 
gene impairs secretion of superoxide dismutase 
and converts H37Rv to an apoptosis-inducing 
phenotype. Mice infected with the secA2 mutant 
demonstrated increased priming of antigen-speci-
fic, MHC class I-restricted immunity. Vaccination 
of mice and guinea pigs with the secA2 mutant 
induced protective immunity superior to BCG. 
Similarly, deletion of nuoG prevented Mtb from 
suppressing macrophage apoptosis and reduced 
its virulence in vivo.
It may be concluded that classical apoptosis of 
Mtb-infected macrophages is largely beneficial for 
the host and detrimental for the infecting bacilli. 
The capacity of Mtb to block TNF-α-mediated 
apoptosis is associated with virulence; it preserves 
the growth-supporting intracellular environment 
while limiting the antimicrobial effects of apoptosis 
and reducing the efficiency of priming adaptive 
immunity. The host has other means to cause 
apoptosis of infected macrophages, including the 
perforin/granzyme and Fas-mediated cell death 
triggered by CTL as well as other innate responses 
that will be described below. In the early stages 
of TB disease, when Mtb adopts a primarily intra-
cellular lifestyle, the outcome of infection would 
thus appear to depend on the relative success of 
the host or the pathogen to stimulate apoptosis or 
promote the survival of infected macrophages.
Mtb  USES PROGRAMMED CELL DEATH 
TO EXIT THE MACROPHAGE
Protecting the viability of host macrophages 
preserves an environment that supports intracel-
lular Mtb replication. After infection at low MOI, 
virulent  Mtb strains grow in macrophages by 
suppressing the innate TNF-α-dependent classical 
apoptosis pathway. In order to cause spreading 
infection, however, infecting bacilli must have 
some means to escape from the macrophage after 
reaching an optimal intracellular bacillary load 
and/or depleting metabolic resources provided by 
the host cell. Recently Lee et al.
42 reported that 
virulent strains induce a non-classical mode of 
macrophage cell death as way to exit the macro-
phage. This death is triggered when the intra-
cellular bacillary load passes a threshold of appro-
ximately 20 bacteria per macrophage. It can be 
modeled by directly infecting macrophages at 
MOI ≥25 but it is also observed when macrophages 
infected at low MOI are cultured for several days, 
permitting the intracellular bacteria to multiply 
up to the threshold load for cytopathicity. Park et 
al.
44 infected macrophages at MOI 5 with several 
virulent  Mtb strains having different rates of 
intracellular replication and found that those 
strains with the fastest growth rates killed their 
host cells after reaching ~15 to 22 colony-forming 
units per cell 6 days later. If Mtb replication was 
inhibited by treating the infected macrophages 
with IFN-γ, then macrophage viability was 
preserved even in those cells infected with the 
potentially cytopathic strains.
The death mode of heavily infected ("high- 
MOI") macrophages differs profoundly from the 
classical TNF-α-mediated and caspase-dependent 
death that occurs in human primary macrophages 
infected with attenuated bacillary strains at low 
MOI. In contrast to low-MOI apoptosis that is acti-
vated by attenuated bacillary strains and sup-
pressed by virulent strains, cell death at high-MOI 
is most potently induced by virulent Mtb strains.
42 
High-MOI cell death has faster kinetics than low- 
MOI apoptosis. Propidium-iodide (PI) positive 
necrotic cells are detectable within 6 hours of 
high-MOI challenge and there is nearly complete 
annihilation of infected macrophage cultures by 
18 hours. This death mode initially has features of 
apoptosis, including nuclear condensation and 
externalization of phosphatidyl serine (PS) that is 
recognized by binding annexin-V. Unlike classical 
apoptosis there is minimal nuclear fragmentation 
or DNA cleavage and the apoptotic cells progress 
rapidly to secondary necrosis that releases bacilli 
from the confines of apoptotic cell envelopes. The 
term "apoptonecrosis" has been applied in this 
situation but is not favored by the Nomenclature 
Committee on Cell Death and will not be used 
here.
45 Rather, we will use the expression "high- 
MOI apoptosis" to indicate the death mode of 
heavily infected cells that begins with some 
typical characteristics of apoptosis but culminates 
in macrophage necrosis.
Experiments have excluded the involvement of Jinhee Lee, et al. 6
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several established cell death signaling pathways 
in high-MOI apoptosis.
42 Evidence to date in-
dicates no requirement for TNF-α, caspase activity, 
free radicals of oxygen or nitrogen, intracellular 
calcium flux or Toll-like receptor (TLR) signaling, 
all of which have been linked in different reports 
to  Mtb-induced apoptosis. While the death sig-
naling pathway activated by high intracellular 
Mtb load remains to be conclusively established, 
experiments suggest the possibility of lysosomal 
apoptosis. Macrophages heavily infected with Mtb 
were partially rescued from death by pre-treatment 
with cell-permeable inhibitors of cathepsins B and 
L.
42 Blocking lysosomal acidification with bafilo-
mycin A also rescued heavily infected macro-
phages (J. Lee, manuscript in preparation), a finding 
consistent with a lysosomal death pathway since 
the activation of many cathepsins depends on 
lysosomal acidification. Considerations that sup-
port the involvement of lysosomal apoptosis in 
high-MOI cell death are that this death mode can 
operate independently of caspases,
31 and that Mtb 
infection has been shown to promote LMP.
46,47 
Lysosomal membrane destabilization as a cause of 
high-MOI cell death can explain the characteristics 
of early apoptosis followed by rapid necrosis since 
the magnitude of LMP and amount of lysosomal 
enzymes released into the cytosol dictates whether 
this death mode has predominant features of 
apoptosis or necrosis.
48
If high-MOI apoptosis functions as a pathway 
for Mtb to exit the macrophage, then it would be 
expected to lack the direct antimicrobial properties 
of classical TNF-α-mediated apoptosis. In this 
regard, Lee et al.
42 found that bacilli released from 
dying macrophages undergoing high-MOI apoptosis 
were not killed and were capable of subsequent 
extracellular growth. Whether the released bacilli 
are fully intact or suffer any transient compromise 
in their fitness remains to be determined. Inter-
estingly, if naïve macrophages are added to high- 
MOI cultures 3 hours after the initial infection 
then there is fall in Mtb viability. The timing of 
this add-back experiment corresponds to the point 
when the infected cells demonstrate features of 
apoptosis (PS externalization, nuclear condensa-
tion) but have not become necrotic. In contrast to 
that result, if naïve macrophages are added to the 
infected cells at 18 hours, when necrosis is com-
plete, then bacillary growth is not restricted. 
These data indicate that there is a window of 
vulnerability for infecting bacilli in the earliest 
stages of high-MOI apoptosis, but this is lost at 
some point after the bacteria are released into the 
extracellular environment from their necrotic host 
cells. The antimicrobial mechanism operating in 
these experiments has not been defined but the 
conditions appear similar to those described in 
add-back studies with M. avium where effero-
cytosis of apoptotic cells might deliver bacilli to 
a killing phagolysosome in the freshly added 
macrophages. Thus, while high-MOI apoptosis 
has features favorable for spreading infection there 
remains an opportunity for the host to limit the 
damage of poorly controlled bacillary replication.
OTHER DEATH MODES LINKED TO Mtb 
INFECTION
This review focuses on those death modes of 
Mtb-infected macrophages that have received the 
greatest amount of attention in published studies. 
However, it is important to note that several alter-
native mechanisms have been described. One closely 
related phenomenon is Fas-mediated apoptosis. 
Binding of FasL expressed on CTL to Fas expressed 
on Mtb-infected macrophages activates the classi-
cal extrinsic apoptosis pathway and, unsurpri-
singly, results in a bactericidal effect similar to 
TNF-α.
39 In keeping with the model that virulent 
bacilli benefit from apoptosis avoidance the surface 
expression of Fas was shown to be downregulated 
on  Mtb-infected  macrophages, making them in-
sensitive to that death signaling pathway.
In a series of related manuscripts the laboratory 
of Dr. Mauricio Rojas has capitalized on macro-
phage-like cell lines derived from mouse strains 
that are resistant or sensitive to infection with 
BCG. In these studies, Dr. Rojas and colleagues 
describe infection-induced apoptosis that depends 
on the generation of nitric oxide and that is 
further regulated by IL-10 and TNF-α.
49-51 Of 
interest, there is differential susceptibility of cells 
derived from the resistant and sensitive hosts. A 
death signaling pathway operating downstream of 
TLR2 was reported to be stimulated by Mtb  19 
kDa lipoprotein.
52,53 In these experiments, macro-Macrophage Apoptosis in Tuberculosis 7
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phage cytotoxicity was induced by inactivated 
bacteria and even by purified 19 kDa lipoprotein 
alone. Purinergic signaling by ATP ligation of the 
receptor P2X7R has been linked to the non- 
apoptotic death of Mtb-infected macrophages and 
to an antimicrobial mechanism that is distinct from 
that associated with classical, extrinsic apoptosis 
and which might involve the induction of auto-
phagy.
54-56 Altogether, at least six discrete cell death 
pathways have been identified in macrophages 
ingesting or binding pathogenic mycobacteria. 
Differences in the conditions and mechanisms of 
infection-induced macrophage cell death have 
resulted in some confusion in the literature. It is 
reasonable to speculate that these varied results 
are not contradictory but rather reflect the potential 
for multiple pro-death (and pro-survival) signals 
to operate in this setting with particular pathways 
and outcomes predominating depending on vari-
ables including the host species, the source and 
differentiation state of the myeloid host cell, in 
vitro culture conditions, Mtb strain and the MOI.
THE APOPTOSIS/ NECROSIS PARADIGM IN 
TB
The concept that one or more programmed cell 
death modes play an important role in TB patho-
genesis is relatively new, but has gained traction 
in the TB research community. The various studies 
cited above suggest a paradigm where caspase- 
mediated apoptosis of Mtb-infected macrophages 
contributes to host defense while necrosis of these 
cells promotes spreading infection in active TB 
disease. This dichotomy was supported by Pan et 
al.
57 who investigated the host genomic basis for 
a strain of mice that are exquisitely susceptible to 
pulmonary TB. Susceptibility was mapped to a 
locus on chromosome 1 designated sst1 and a 
gene within that locus called Ipr1. Macrophages 
from mice with the susceptible sst1 allele were 
found to undergo predominant necrosis when 
infected with Mtb in vitro. This contrasted with the 
primarily apoptotic death of infected macro-
phages derived from sst1 resistant mice. A key 
observation in this work was that in vivo aerosol 
challenge of Sst1 susceptible mice was associated 
with massive pulmonary necrosis, while the 
histopathology of Mtb-infected Sst1 resistant mice 
showed the focal lesions typical of murine pulmo-
nary TB, lacking any macroscopic necrosis.
In an unrelated study, Gan et al.
58 challenged 
mice at high MOI in vivo with virulent Mtb H37 
Rv or attenuated H37Ra and showed by flow 
cytometry that the virulent strain induced higher 
rates of lung macrophage necrosis and dramatically 
depleted the resident alveolar macrophage popu-
lation, while H37Ra caused significantly less 
necrosis and only partially reduced the resident 
macrophage population. Interestingly, the necrotic 
environment of the H37Rv-infected lung produced 
dramatically higher rates of neutrophil recruit-
ment. While speculative at present, it is tempting 
to conclude that the newly described necrosis 
sensing receptor Mincle
59 is responsible for the 
pulmonary neutrophilia associated with H37Rv- 
induced macrophage necrosis.
The reports by Pan and Gan associate necrosis 
with TB susceptibility, while the previously refer-
enced studies with secA2 and nuoG Mtb mutants 
clearly demonstrate the enhancement of host 
defense when certain forms of macrophage apop-
tosis are promoted.
40,43 A model is emerging 
wherein the success of initial infection by Mtb de-
pends on the pathogen's capacity to inhibit activa-
tion of the extrinsic apoptosis pathway in the host 
macrophage. The host has several alternative 
proapoptotic avenues available, including innate 
TNF-α  death signaling as well as apoptosis in-
duced by the adaptive CTL response through Fas 
signaling and by the action of perforin/granzyme. 
If apoptosis predominates then infection may be 
aborted and potentially cleared. However, if 
virulent bacilli succeed in suppressing caspase- 
mediated apoptosis of their host cells the bacilli 
may increase in number and subsequently activate 
a non-classical "high-MOI" death mode that pro-
gresses rapidly to necrosis. Macrophage necrosis 
promotes spreading infection to naïve macroph-
ages and might also contribute to the macroscopic 
necrosis that characterizes advanced TB lesions. 
While adaptive immunity is thought to contribute 
to this destructive pathology, there is also evidence 
for an innate component
60 that could be reflective 
of high-MOI apoptosis occurring within TB 
granulomas. In this regard, Gil et al.
61 reported 
that necrosis of TB lesions in the lungs of infected Jinhee Lee, et al. 8
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mice was related to bacterial load and could not 
be attributed to the function of any particular T 
cell subset or cytokine. It has recently been 
appreciated that Mtb imports and metabolizes 
cholesterol,
62 suggesting that necrosis could help 
create a cholesterol-rich milieu
63 geared to support 
extracellular bacillary survival, growth and trans-
mission to the next human host.
Elucidating the interactions between Mtb and 
macrophages that culminate in the death of the 
infected cell (and in some circumstances the death 
of infecting bacilli) furthers our understanding of 
TB pathogenesis and could ultimately impact the 
diagnosis, treatment and prevention of TB. Apop-
totic macrophages have been recovered by bron-
choalveolar lavage of humans with TB.
64 While it 
is likely that dying cells will be present in the 
setting of diverse respiratory infections there is 
nonetheless potential that the presence and 
quantity of these cells might serve as a biomarker 
for active TB disease. In settings of poorly con-
trolled mycobacterial replication one would pre-
dict an increased ratio of necrotic to apoptotic 
cells. Indeed, Sanchez et al.
65 reported that peri-
pheral blood monocytes from TB patients demon-
strated apoptosis and necrosis when infected ex 
vivo with H37Rv, while monocytes from healthy 
controls exhibited only apoptosis.
There is active investigation and development 
of drugs to regulate cell death responses for thera-
peutic indications including cancer, cardiovas-
cular disease, neurodegenerative diseases, and 
aging among others.
66,67 Drugs that enhance classi-
cal apoptosis or those that inhibit the high-MOI 
death mode could have therapeutic value, while 
those with opposite effects could be detrimental to 
host defense in TB. The potential negative and 
positive impact of immune-modulating therapies 
on the risk for reactivation of latent TB infection 
and the treatment of active TB disease has been 
highlighted by the association of infliximab with 
TB susceptibility
68 and by reports of treating TB 
patients with recombinant IFN-γ,
69 respectively. It 
is clear that the evaluation of safety and efficacy 
for any novel drugs regulating cell death must 
consider their possible impact on the survival and 
death mode of Mtb-infected macrophages.
Perhaps the clearest near-term translational 
relevance of apoptosis in TB is in the field of 
vaccine development. Dr. Stefan Kaufmann and 
colleagues developed an experimental recombi-
nant BCG strain that is presently in phase I clini-
cal trials. This strain expresses the listerolysin O 
toxin (LLO) of Listeria monocytogenes and is also 
mutated to delete the mycobacterial urease gene.
70 
The original concept was to promote the cross- 
presentation of BCG antigens on MHC class I 
through the action of LLO to permeabilize the 
mycobacterial vacuole and allow antigens to gain 
access to the cytosol. The urease mutation was 
designed to potentiate acidification in order to 
maximize the biological activity of LLO. Preclini-
cal studies confirmed the potent immunogenicity 
of this candidate vaccine but also revealed that its 
potency is at least in part due to the induction of 
macrophage apoptosis. This discovery could lead 
to the development of even more effective vectors 
(or particles) building on the observation that 
apoptosis of infected macrophages enhances the 
priming and cross-priming of adaptive immunity. 
Future experiments may define the optimal char-
acteristics of apoptotic bodies that promote antigen 
presentation and incorporate this knowledge into 
vaccine design.
CONCLUSION
Our understanding of TB pathobiology has 
become progressively deeper and more refined 
since the identification of Mtb as the etiologic 
agent of disease by Dr. Robert Koch in 1882. 
Incorporating concepts of macrophage program-
med cell death following Mtb infection is a 
relatively recent addition to this knowledge base. 
We propose that following inhalation of infectious 
aerosols,  Mtb bacilli invade lung macrophages 
and increase in number by intracellular replica-
tion. Host macrophages sense infection and may 
respond by undergoing TNF-α-mediated apoptosis 
and possibly through other cell death pathways. 
Apoptosis contributes to host defense by elimi-
nating the niche for Mtb growth, by direct anti-
microbial effects on intracellular bacilli, and by 
packaging  Mtb bacilli and antigens in apoptotic 
bodies. The subsequent engulfment of these 
apoptotic bodies by newly recruited macrophages 
and dendritic cells promotes the eradication of Macrophage Apoptosis in Tuberculosis 9
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infection and the induction of the adaptive im-
mune response. Virulent Mtb strains actively 
suppress apoptosis of the host macrophage to 
protect their replicative niche. After proliferating 
to a high intracellular load virulent bacilli trigger 
a necrotic mode of macrophage cell death, releasing 
them to infect new host cells and ultimately to 
grow as extracellular pathogens in necrotic cavities. 
While much remains to be learned, the em-
erging model of macrophage apoptosis as bene-
ficial to host defense and macrophage necrosis as 
a mechanism for spreading infection is becoming 
widely accepted. This is a complex topic, with the 
likely involvement of diverse and potentially 
competing cell death pathways and pro-survival 
signals that have different implications for the 
host and infecting pathogen. As with all new basic 
knowledge in biomedicine, the clinical signifi-
cance of this work will only become clear as new 
information is incorporated into the design and 
evaluation of novel therapeutics. Given the central 
role that macrophage apoptosis plays in TB patho-
genesis and to the induction of adaptive immu-
nity, it is likely that new vaccines and potentially 
new therapies based on this knowledge will emerge 
in the coming decade.
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